New combo pill for fluid retention put to the test
NCT ID NCT07015671
First seen Nov 03, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study looked at how a new extended-release tablet combining two heart medications (torsemide and spironolactone) works in 24 healthy adults. The goal was to see if the combination pill is absorbed the same way as taking the drugs separately. This helps ensure the new pill is safe and effective for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sarfez Pharmaceuticals
Vienna, Virginia, 22182, United States
Conditions
Explore the condition pages connected to this study.